AMPH

Amphastar Pharmaceuticals Inc.

Price

$21.74

return (12m)

-28.32%

p/e

11.68

p/bv

1.19

DIVIDEND YIELD

0.00%

AMPH price

Amphastar Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AMPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.22%

3 months

19.71%

1 year

-28.32%

2 years

-53.54%

5 years

15.09%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AMPH

Valuation

P/E

11.68

Sector -2.19

Industry 1.21

P/BV

1.19

Sector 2.22

Industry 2.11

P/Revenue (PSR)

1.26

Sector 2.01

Industry 0.78

EV/EBITDA

20.07

Sector -17.81

Industry -25.30

EV/EBIT

27.37

Sector -26.72

Industry -18.04

P/EBITDA

4.76

Sector 0.36

Industry 0.18

P/EBIT

7.16

Sector -3.34

Industry 1.26

P/Total Assets

0.53

Sector 1.23

Industry 0.86

P/Net Current Assets

-2.66

Sector -27.35

Industry -12.37

P/Working Capital

2.50

Sector -4.54

Industry -49.48

EPS

1.79

Sector -0.87

Industry -0.55

BVPS

17.46

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

47.69%

Sector 43.36%

Industry 31.53%

EBITDA Margin

33.53%

Sector -323.65%

Industry -73.39%

EBIT Margin

24.58%

Sector -194.57%

Industry -11.94%

Operating Margin

15.66%

Sector -24.37%

Industry -9.87%

Net Profit Margins

10.76%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.11

Sector 0.12

Industry 0.22

Profitability

ROE

10.23%

Sector -33.82%

Industry -37.56%

ROA

4.50%

Sector -29.63%

Industry -17.56%

ROIC

10.41%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.40

Sector 1.84

Industry 1.14

Net Debt / EBITDA

5.18

Sector -1.47

Industry -31.86

Net Debt / EBIT

7.07

Sector -1.32

Industry 2.06

Net Debt / Equity

0.42

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.79

Sector 0.14

Industry 0.51

Equity/Assets

0.44

Sector 0.42

Industry 0.25

Liabilities/Assets

0.56

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

10.77%

Sector -

Industry -

5Y Earnings CAGR

4.81%

Sector -

Industry -

FAIR VALUE OF Amphastar Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$21.74

Fair Value

$26.52

Upside Return potential.

21.98%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals AMPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AMPH Amphastar Pharmaceuticals Inc.	$21.74	-28.32%	0.00%	11.68	1.19	10.23%	10.76%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AMPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

22 years

Founded: 2004

2014

Time since IPO - 12 years

354

Employees

Amphastar Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $917.84 million, with shareholders equity totaling $768.16 million.

The company employs approximately 354 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Amphastar Pharmaceuticals Inc. reported $730.01 million in revenue, generating net income of $78.55 million.

Key financial metrics include a P/E ratio of 11.68, a price-to-book (P/B) ratio of 1.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMPH.

Market cap

$917.84 million

Net worth

$768.16 million

$768,160,000.00

Assets

$1.74 billion

$1,743,770,000.00

Total Shares Outstanding

44.00 million

44,000,000

Average Daily Trading Volume

$515.06 Thousand

$515,061.62

Sector

Health

Industry

Pharmaceutical Products

AMPH

AMPH revenue and profits

Financial Results AMPH

DRAG THE FRAME TO SEE MORE DATA

AMPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87